Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma

Most patients with hepatocellular carcinoma (HCC) are diagnosed when the disease is already at an advanced stage, so they are not eligible for resection and their prognosis is poor. The combination of transarterial chemoembolization (TACE) with immune checkpoint inhibitors or tyrosine kinase inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kang, Luo, Cheng-Piao, Ge, De-Xiang, Wang, Ke-Lin, Luo, Qin, Li, Yan-Zhi, You, Xue-Mei, Xiang, Bang-De, Li, Le-Qun, Ma, Liang, Zhong, Jian-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583878/
https://www.ncbi.nlm.nih.gov/pubmed/36276151
http://dx.doi.org/10.3389/fonc.2022.946693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583878/
https://www.ncbi.nlm.nih.gov/pubmed/36276151
http://dx.doi.org/10.3389/fonc.2022.946693

Ejemplares similares